Reducing the risk of NAION involves managing underlying health conditions that contribute to its development, he told us
The pharmacokinetics of tirzepatide after a single 5 mg dose was evaluated in patients with different degrees of hepatic impairment (mild, moderate, severe) compared with subjects with normal hepatic function [see Use in Specific Populations (8.7)]
Cannabis use disorder, defined as an inability to stop using marijuana despite adverse health effects or social problems, is associated with increased occurrence of AFib, hospital admissions for uncontrolled AFib and thromboembolic events, the authors wrote
The molecule is built on native human GLP-1(7-37) with three structural modifications
This primarily appears to be due to clinical results since GLP-1s lower A1C, reduce weight, improve cardiovascular outcomes, and potentially many other benefits